Tag: APRE

Aprea Therapeutics has recently been granted FDA approval for its Investigational New Drug (IND) application for APR-1051, a cutting-edge WEE1 ...

Aprea Therapeutics, a cutting-edge biopharmaceutical company, has recently unveiled a private placement financing round expected to reach $34 million. Spearheaded ...